Is permethrin safe to use in patients with abnormal liver function tests (LFTs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

This drug is known to be substantially excreted by the kidney However, since topical permethrin is metabolized in the liver and excreted in the urine as inactive metabolites, there does not appear to be an increased risk of toxic reactions in patients with impaired renal function when used as labeled.

The use of permethrin in patients with abnormal liver function tests is not directly addressed in the provided drug label. However, it is mentioned that permethrin is metabolized in the liver.

  • There is no explicit warning regarding the use of permethrin in patients with abnormal liver function tests.
  • The label does mention that permethrin is excreted in the urine as inactive metabolites. Given the lack of direct information, a conservative clinical decision would be to exercise caution when using permethrin in patients with abnormal liver function tests, as the potential effects on liver function are not clearly stated 1.

From the Research

Permethrin is generally considered safe for patients with abnormal liver function tests (LFTs) as it has minimal systemic absorption when applied topically. The standard treatment for scabies and lice involves applying 5% permethrin cream from neck to toes, leaving it on for 8-14 hours, then washing it off. Unlike oral medications that require hepatic metabolism, permethrin works locally on the skin with less than 2% being absorbed into the bloodstream. This limited systemic exposure means that liver impairment typically doesn't significantly affect permethrin's safety profile or require dose adjustments.

However, patients with severe liver disease or those with extensive skin breakdown (which could increase absorption) should be monitored more closely for potential adverse effects. If treating a patient with significantly compromised liver function, consider consulting with a specialist before treatment, though alternatives like benzyl benzoate may have more hepatic concerns 2, 3, 4. The most common side effects of permethrin are mild skin irritation, burning, or stinging at the application site rather than systemic effects. It's worth noting that while ivermectin has been associated with liver injury in some cases 5, 6, permethrin has a different mechanism of action and is not typically associated with significant liver toxicity.

Some key points to consider when evaluating patients with abnormal LFTs include:

  • The pattern and severity of liver injury can provide clues about the cause of disease and should guide diagnostic evaluation 3, 4
  • A systematic, stepwise approach to the evaluation and management of abnormal liver test results is recommended to optimize high-value care 3
  • Patient with signs or symptoms of liver disease or abnormal liver test results should be evaluated to determine the etiology 4
  • Tests should include a complete blood cell count; alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total bilirubin, and albumin levels; prothrombin time; hepatitis B surface antigen; hepatitis B core antibody; hepatitis C antibody; ferritin and iron levels and transferrin saturation; and right upper quadrant abdominal ultrasonography 4.

References

Research

Evaluation of abnormal liver function tests.

Postgraduate medical journal, 2016

Research

Care of the Patient With Abnormal Liver Test Results.

Annals of internal medicine, 2021

Research

Ivermectin drug induced liver injury.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.